Glucagon-like Peptide -1 Receptor Agonist (GLP1a) Use in Patients Presenting for Gastroenterology Procedures A Review of Concerns

Overview: Linda Wunder, PhD, CRNA, APRN, FAANA and Rebecca Lee, DNP, CRNA, APRN, FAANA present "Glucagon-like Peptide -1 Receptor Agonist (GLP1a) Use in Patients Presenting for Gastroenterology Procedures A Review of Concerns" on behalf of SGNA.

 At the conclusion of this presentation, the participants will be able to:

• Discuss the glucose homeostasis, dysfunction of GLP, and insulin resistance.
• Analyze the effects of gastroparesis and the GI suite.
• Explore the Pharmacodynamics of Glucagon-like Peptide-1 receptor agonist.
• Consider the differences in management of patients taking GLP-1a and GIP medications. Apply knowledge of providing safe GI environment for those patients taking GLP-a and GIP medications

The Society of Gastroenterology Nurses and Associates, Inc., is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation. 

Contact Hours: This webinar is worth 1.0 contact hour(s). Contact hour(s) expire on 8/19/2028. 

Successful Completion of this accredited continuing education activity is based on:

1) Being registered for this activity,

2) Attendance of this activity,

3) Completion of the Evaluation. 

SGNA is provider-approved by the California Board of Registered Nursing, Provider Number CEP 11579. Check with your state board of nursing for acceptability of education sessions for re-licensure.